Millennium Management »

Xilio Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $17k 30k 0.55
2023-06-30 $34k 13k 2.62
2023-03-31 $53k 17k 3.16
2022-12-31 $72k 27k 2.68
2022-06-30 $146k 50k 2.92

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Amazon Put Option (AMZN)
Meta Platforms Cl A (META)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
salesforce Put Option (CRM)

View all positions for Millennium Management

Top funds holding Xilio Therapeutics

Atlas Venture Life Science Advisors
Octagon Capital Advisors
RiverVest Venture Management
Vanguard Group
Artal Group
Laurion Capital Management
Arrowpoint Asset Management
Citadel Advisors
Millennium Management
PFG Investments
Summit Trail Advisors
Charles Schwab Investment Management
Virtu Financial
Dunhill Financial
Jpmorgan Chase & Co

View all funds holding Xilio Therapeutics